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Abstract
This paper critically discusses two previous studies concerned with predictions of HIV/AIDS in the
United States and Japan during the early 1990s. Although the study in the US applied a historical
theory, assuming normal distribution for the epidemic curve, the underlying infection process was
not taken into account. In the Japan case, the true HIV incidence was estimated using the coverage
ratio of previously diagnosed/undiagnosed HIV infections among AIDS cases, the assumptions of
which were not supported by a firm theoretical understanding. At least partly because of failure to
account for underlying mechanisms of the disease and its transmission, both studies failed to yield
appropriate predictions of the future AIDS incidence. Further, in the Japan case, the importance of
consistent surveillance data was not sufficiently emphasized or openly discussed and, because of
this, revision of the AIDS reporting system has made it difficult to determine the total number of
AIDS cases and apply a backcalculation method. Other widely accepted approaches can also fail to
provide perfect predictions. Nevertheless, wrong policy direction could arise if we ignore
important assumptions, methods and input data required to answer specific questions. The present
paper highlights the need for appropriate assessment of specific modeling purposes and explicit
listing of essential information as well as possible solutions to aid relevant policy formulation.
Background
Although numerous mathematical and statistical
approaches have been proposed to predict the future
course of infectious diseases, various assumptions are
required to account for the intrinsic and extrinsic dynam-
ics of disease spread [1-3], and consequently, detailed
models require specialized knowledge. Thus, it is often
the case that the majority of non-experts directly adopt the
predictions or estimates as given, neglecting key assump-
tions and/or significant flaws. This paper critically dis-
cusses two previous studies concerned with predictions of
HIV/AIDS in the United States and Japan. Through these
case studies, which include relatively obvious technical
problems related to the intrinsic assumptions, I examine
how model-based suggestions are interpreted among
non-experts and attempt to suggest potential solutions for
general quantitative models relevant to policy making.
Analysis
Mathematical and statistical models of HIV/AIDS 
epidemiology
Before entering into discussion on the details of the case
studies, two widely accepted models of HIV/AIDS epide-
miology are briefly discussed. Whereas there is no single
best method for AIDS prediction, these two approaches,
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both of which were initially proposed during the late
1980s, are widely employed [4-10].
The first approach is based on a mathematical model that
explores the population dynamics of HIV/AIDS [1,11].
The model is constructed in a bottom-up fashion, facilitat-
ing understanding of the qualitative patterns of transmis-
sion dynamics. It should be noted that some studies
employ this method to explore qualitative or analytical
features only [2], offering ecological implications (e.g.,
regarding evolutionary biology [12]) based on the
observed qualitative patterns. The pioneering model on
HIV/AIDS [4,7] and technical reviews of this model are
given elsewhere [13,14]. Quantitative application of this
approach is typically represented by the estimations and
predictions performed by the Joint UN Programme on
HIV/AIDS (UNAIDS) mainly in developing countries [15]
using observed HIV prevalence data (e.g., from antenatal
clinics or military personnel). Although the model struc-
ture and assumptions vary depending on the specific pur-
pose of the study, advantages of this approach include a
firm understanding of the intrinsic dynamics (e.g., how
the contact structure contributes to the spread of HIV)
[16,17] and analysis of the potential impact of interven-
tions on HIV/AIDS epidemiology [18].
The second model, referred to as backcalculation, is a
more statistically motivated approach to estimating HIV
prevalence [8-10]. Backcalculation uses the statistical dis-
tribution of incubation period as key information, and is
frequently applied to HIV/AIDS in industrialized coun-
tries where the previous AIDS incidence can be assumed
to be confidently diagnosed and reported. The epidemic
curve for HIV is reconstructed using AIDS incidence and
the incubation period, enabling estimation of HIV preva-
lence and short-term projections of AIDS incidence. Since
this paper mainly deals with HIV/AIDS in industrialized
countries, the simplest form of this estimation method is
given in Additional file 1, with technical details available
elsewhere [19-21].
Neither the US nor Japan case studies used the above
methods, and further, whereas the above two approaches
account for underlying mechanisms of the disease, the
two case studies focused almost entirely on extrapolation
of the epidemic curve.
The United States case
The approach employed in the US case study assumed a
normally distributed epidemic curve [22]. The underlying
theory, referred to as Farr's law [23], was used in the late
1980s with direct application of the concept to the annual
incidence of AIDS in the US [24,25]. Fig.1 shows the inci-
dence of adult AIDS cases in the US by year of diagnosis
from 1981–2003 [26,27] along with the predictions
obtained in the above case study based on Farr's law [22].
Since the data include all routes of transmission, and
because of the revised definition of diagnostic criteria and
corrected number of cases, the annual incidence in Fig. 1
is slightly higher than in the original study [22], while
maintaining similar trends and prediction results. Techni-
cal details are given in Additional file 1.
The Japan case
As the Japan case study, the series of studies by the Work-
ing Group on prediction of HIV-infected cases and AIDS
patients, organized by the Ministry of Health, Labor and
Welfare (MHLW), Japan, are discussed [28-31]. From the
very first study [28], the ratio of previously reported AIDS
cases to unreported cases was used as key information,
assuming that it was equivalent to the "coverage rate" of
reported HIV infection (note: precisely, the 'ratio', not
'rate', of reported to unreported AIDS was used). In other
words, it was assumed that the true HIV incidence could
be estimated using the number of reported HIV infections
with the coverage ratio directly obtained from the ratio of
previously diagnosed (reported) to undiagnosed (unre-
ported) AIDS cases. Thus, the following relationship was
assumed:
where Hu, Hd, Au, and Ad are the cumulative number of
unreported and reported HIV infections and unreported
and reported AIDS cases, respectively. The ratio has been
revised several times, but the most recent studies adopt an
estimate of 1/5.1 (reported/unreported), because approx-
imately 19.6% of the AIDS cases reported up until the
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Observed and predicted AIDS incidence in the United States  from 1981–2003 Figure 1
Observed and predicted AIDS incidence in the 
United States from 1981–2003. Data source: refs. 
[26,27]. Details of the underlying assumptions employed are 
described in the Additional file. The prediction was obtained 
using the data up to the dashed line; i.e., from 1981–7. The 
constant second ratio of AIDS incidence was 0.8647, as 
adopted in ref. [22].Epidemiologic Perspectives & Innovations 2007, 4:3 http://www.epi-perspectives.com/content/4/1/3
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mid-1990s were previously diagnosed as being infected
with HIV [30,32].
The ratio should be implicitly assumed to be independent
of time. Using the estimated HIV prevalence based on this
ratio, it is assumed that HIV-infected individuals develop
AIDS according to a fixed incubation period distribution
that follows Weibull distribution [28-30]. Based on the
above assumptions, the future number of HIV infections
as well as the future AIDS incidence was obtained, assum-
ing that a constant increase in HIV infections would occur
[28,29]. That is, a linear trend was adopted for the reports
of HIV infection.
Failure to reflect the reality
As shown in Fig. 1, the AIDS projection obtained in the US
assuming a normal distribution for the temporal pattern
of AIDS incidence failed to reflect the reality. Considering
the shape of the epidemic curve and that the actual peak
of AIDS incidence was seen later than predicted, it seems
that the basic assumptions of this projection were inap-
propriate, resulting in serious underestimation. The inac-
curacy was suggested immediately after publication of the
original study [33]. Their argument was based on an HIV
seroprevalence survey conducted in the late 1980s in
which the estimated prevalence of HIV was 5-fold larger
than the predicted cumulative number of future AIDS
cases obtained from normal distribution [34].
The original study did not take into account the reason
behind the assumption of a normal curve [22,35]. Non-
normal distribution originates from the characteristics of
the nationwide data under the influence of immigration
of infected individuals, a right-skewed incubation period
distribution of HIV infection and further modification as
a result of antiretroviral therapy [36]. However, a more
significant flaw concerns the reason why a symmetric bell-
shaped curve could be assumed for the epidemic curve.
Provided that the assumption of a normal distribution
had been empirically confirmed, the technical problems
related to HIV/AIDS-specific intrinsic dynamics might
have been justifiable during the 1980s. The potential rea-
son for assuming a normal epidemic curve is given in
Additional file 1, but was not appropriately understood in
the US study.
Figs. 2a–c show the predicted true HIV incidences based
on the above mentioned assumptions for three major
routes of transmission in Japan. The annual reported
number of HIV infections from 1985–1992 and a cover-
age ratio of 1/5.1 were used for these predictions. The
observed true HIV incidences in the figure were obtained
by multiplying the inverse of the coverage ratio (5.1) by
the reported number of HIV infections in each year. Figs.
2d–f compare the observed and predicted AIDS inci-
dences based on the HIV prevalence estimates shown in
Figs. 2a–c. For all three routes of transmission, the predic-
tions were clearly overestimated compared to the actual
AIDS incidence. Although later work applied a dynamical
system to exploration of the potential impacts of interven-
tions [31], the data source for this model was also based
on estimates of true HIV incidence using the coverage
ratio. There were two obvious technical flaws: (1) a linear
growth trend for HIV was adopted without extensive vali-
dation, and (2) the coverage ratio did not approximate the
ratio of previously reported to unreported HIV infections.
Analytical discussion of the latter point is highlighted in
Additional file 1.
The impact of these failures on public health
A number of professionals immediately and sharply criti-
cized the US projection [22,33,36,37]. Issues related to
the extrapolation of epidemic curves, the functional form
of which significantly influences the predictions, are
explained in detail elsewhere [35]. In addition to these
immediate criticisms and a technical review of HIV/AIDS
predictions [33-37], at least another six articles referenced
the US study [38-43]. Although technical criticisms
regarding the obvious flaws have been noted, and even
though care seems to have been taken to appropriately
interpret the prediction, the US study was simply
described as ''a more conservative estimate'' in a general
policy publication reviewing various predictions in the US
[38].
Some publications, which did not follow the widely dis-
cussed theoretical concepts, investigated the original
study as an accepted theory or extended the discussion
concerning predictability. Shortly after publication of the
original study and more recently [39,40], the above anal-
ogy was referenced as formal theoretical evidence explain-
ing the mechanistic process of the bell-shaped pattern of
AIDS incidence. Similarly, the original study has been ref-
erenced several times as a theory explaining the declining
pattern of HIV infections [41,42]. Moreover, a lack of care-
ful interpretation among non-experts has also led to
another epidemiologic flaw. A later study suggested the
usefulness of a simple linear regression (rather than Farr's
law), claiming that the regression left less than 10% resid-
ual variance in incidence [43]. Even though criticisms
were made among specialists, and thus, the original study
had little impact on public health in the US, non-experts
often remain unaware of the detailed mechanism of dis-
ease spread (i.e., the reason why the original study did not
reflect the reality).
In Japan, the Committee of AIDS Trends, formed by
MHLW, expressed their standpoint with respect to inter-
pretation of such estimations as follows [44]: "Because
there are various methods that could be used for estima-
tions, the Committee considers it difficult to identify the
single best method. Thus, it is not appropriate to presentEpidemiologic Perspectives & Innovations 2007, 4:3 http://www.epi-perspectives.com/content/4/1/3
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estimated numbers using a specific method. Rather, we
suggest that the estimates of individual researchers should
be employed while referring to the underlying assump-
tions or hypothesis of the methods used" (author's trans-
lation). Studies based on the presented Japan case study
[28-31] as well as on different assumptions [45] were
given as references in this report. Unfortunately, the latter
study was similarly not based on widely accepted intrinsic
assumptions [45]. Despite the above statement, the find-
ings of the Japan studies [28-31] are most frequently
adopted as official estimates [46,47], because only these
studies consecutively provided predictions for Japan.
The Japan case study also indirectly influenced the AIDS
notification method. Prior to revision of the surveillance
system in 1999, HIV/AIDS notifications among Japanese
nationals were classified into one of three categories: (1)
HIV infection, (2) AIDS without a previous diagnosis of
HIV infection (= 'First Report'), and (3) AIDS with a pre-
vious HIV diagnosis (= 'Second Report'). Since implemen-
tation of the Law Concerning the Prevention of Infectious
Diseases and Medical Care in 1999, replacing the previous
law for HIV/AIDS in Japan, it has become difficult to link
individuals initially categorized as (1) and later as (3) due
to the altered administrative system [48]. Moreover, the
Second Report was often delayed because many physi-
cians did not feel particularly obliged to report AIDS cases
that had already been documented as HIV infected [32].
Thus, owing to the suggestion that 'Second Reports are
confusing', they became non-obligatory after 1999 and,
since then, individuals categorized as such have not been
included in the total number of AIDS cases. This made it
impossible not only to assess the robustness of the
assumption using the coverage ratio but also to perform
estimations using backcalculation, which essentially
requires the total number of AIDS cases [8-10]. If the
importance of the total number of AIDS cases had been
sufficiently highlighted and openly discussed in detail,
revision of the reporting system would not have been nec-
essary.
Policy-making and the modeling framework
The two case studies discussed here employed rather dif-
ferent approaches compared to widely accepted methods.
In the US, experts in relevant fields criticized the original
study and the flawed prediction has become relatively
Observed and predicted numbers of HIV infections and AIDS diagnoses in Japan from 1985–2004 Figure 2
Observed and predicted numbers of HIV infections and AIDS diagnoses in Japan from 1985–2004. Data source: 
ref. [44]. The top three panels show the estimated true HIV incidence (a-c) and the bottom show AIDS incidence (d-f). The 
routes of transmission are heterosexual men (a and d), men who have sex with men (MSM; b and e), and heterosexual women 
(c and f). The prediction was obtained using the data up to the dashed line; i.e., from 1985–92. The straight lines in a-c repre-
sent the predicted true HIV incidence based on the assumption of linear growth. The coverage ratio was 1/5.1 [30,32]. The 
shape and scale parameters for the Weibull distribution used to describe the incubation period were 2.286 and 10.0, respec-
tively, as adopted in ref. [28].Epidemiologic Perspectives & Innovations 2007, 4:3 http://www.epi-perspectives.com/content/4/1/3
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well known, at least among specialists. Although there
were few public health impacts (including the data collec-
tion method), a few non-experts, who seem not to recog-
nize the importance of intrinsic dynamics, continue to
reference and extend the original theory. Moreover, the
predictions obtained based on the original Japan case
study have been largely adopted as official, and unfortu-
nately, only one study has so far criticized the technical
flaw [49]. The following three points summarize what
should be addressed. Many of the criticisms below are
also common concerns for widely accepted models.
a) Common pitfalls in model-building
It should be accentuated that intrinsic dynamics are one of
the most important factors offering valid and sound
answers to the specific question addressed by the model
(e.g., AIDS prediction in the above case studies) [50].
Transmission dynamics should be explored because
observations of different individuals cannot be consid-
ered independently when studying infectious diseases.
Although many widely accepted models have not over-
come uncertainty or achieved precise predictions, their
impact on our understanding of the epidemiologic proc-
ess of HIV/AIDS have been discussed elsewhere [11,51].
The above two case studies were most likely unaware of
the importance of intrinsic dynamics. This technical point
should be further consulted elsewhere [11,50,52,53].
b) General assessment of prediction
It should be emphasized that even if a model has good
predictability it does not necessarily mean it's a good
model for prediction. It should also be noted that good
models are essentially accompanied by valid basic
assumptions of the spread of disease and pay close atten-
tion to the input parameters; the widely accepted
approaches take particular care to heed this point. As in
the above two case studies, the majority of flawed predic-
tions employ simple extrapolation of an epidemic curve,
the most uncertain component of modeling, frequently
focusing on the predicted value itself or simple residual
variance alone.
c) Assessment of modeling studies for policy making
One of the biggest challenges facing modelers and policy
makers is how to communicate and share these points
effectively [53]. Many researchers, including epidemiolo-
gists in other fields, do not sufficiently understand the
basic model structures as well as key assumptions. Fur-
ther, for the general reader, there are no general rules for
evaluating original studies or critically assessing modeling
studies. This is the case not only in the presented extreme
cases but also with other common approaches frequently
employed. Further, it is not uncommon for the scope and
key assumptions to be insufficiently shared with policy
makers before entering into detailed discussion of their
predictability.
Potential solutions
The criticisms presented here do not blame the authors of
the presented case studies, but rather attempt to give gen-
eral suggestions for improvement. As a possible remedy
for modeling frameworks, to make them truly useful for
policy making, I suggest the following potential solutions.
These apply not only to the above discussed extreme cases
in the US and Japan but also to most quantitative models.
a) Purposes of modeling
The model structure depends on investigation of a specific
question. Even if based on valid assumptions, it must be
remembered that models may not provide any insights
other than their main purpose. Thus, what can and cannot
be learned from each study must be explicitly docu-
mented for the reader to assess. If more than two quanti-
tative approaches are applied to the same data, the
purposes and information obtained could be different. It
is not uncommon for various approaches to be applied to
the same data, with the generated findings enhancing our
understanding of the validity of the assumptions made.
Thus, where possible, various approaches that differ from
each other in their purposes should be applied to the
same data.
b) List of assumptions, limitations and parameters
As discussed above, the validity of estimations and/or pre-
dictions largely depends on the assumptions made. Thus,
it would be very useful if all publications documented the
assumptions, limitations and input parameters in an
explicit manner (for example, see [54,55]). Although such
documentation is a widely accepted practice in current
modeling papers, it might be further useful if the informa-
tion was systematically listed. Moreover, it would be
worth documenting the role of each parameter employed,
the source of the parameter estimates, and the geographic
representativeness. For policy makers, it might be useful
to check if modeling studies follow such rules of listing.
c) Assumptions employed to answer specific questions
Most modeling frameworks are accompanied by a certain
number of unrealistic assumptions. Despite efforts to
make a model as realistic as possible, it is often the case
that the data is limited, e.g., as a result of future improve-
ments in treatments or behavioral changes. It should be
noted, however, that incorporation of numerous details is
not necessarily a remedy for inappropriate description of
the reality. Depending on the question being addressed,
an accurate yet simplistic model may be desirable; a sim-
ple model often better reflecting the reality than complex
simulations [11]. In line with this, non-experts are advised
to assess two points regarding such studies: (1) whetherEpidemiologic Perspectives & Innovations 2007, 4:3 http://www.epi-perspectives.com/content/4/1/3
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the model successfully answers the addressed question in
a simple fashion, and (2) whether the assumptions made
are sound and sufficiently realistic.
d) Policy formulation
Modelers should fully understand the intrinsic dynamics
of the disease and/or work closely with specialists who
can offer detailed disease information. Since it is not
uncommon for the findings of a model to be misinter-
preted (as in the above case studies), it is crucial that mod-
elers, policy makers, and clinicians work together when
creating and utilizing such models. Through such practice,
modeling experts should share their knowledge in assess-
ing the validity of a model and translating the implica-
tions for policy makers. Further, if public health officials
are unable to assess the findings of model-based predic-
tions, modelers should be on hand for consultation.
These experts should also employ their knowledge to dis-
ease monitoring systems.
Conclusion
The present study critically discussed two predictions of
AIDS incidence with the aim of understanding how such
estimates are interpreted by the general public and explor-
ing possible improvements in policy making. It should be
emphasized that ignoring how a disease spreads, and
related assumptions, as well as neglecting key input infor-
mation could lead to wrong policy direction. The need for
appropriate assessment of specific modeling purposes,
and explicit listing of assumptions, limitations and
parameter inputs as well as possible solutions to aid rele-
vant policy formulation was therefore highlighted.
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